Even during a down period for the markets, Pfizer has gone against the grain, climbing to $28.30. Its shares have yielded a 7.1% return over the last six months, beating the S&P 500 by 9.4%.
- Even during a down period for the markets, Pfizer has gone against the grain, climbing to $28
- 30
- Its shares have yielded a 7
Sign up free to read the full analysis
Create a free account to unlock full AI-curated market articles, personalized alerts, and more.
Share this article